PAPER Korte M, Herrmann U, Zhang X, Draguhn A
SEARCH RESULTS
331008 RESULTS
PAPER Medina M, Garrido JJ, Wandosell FG
Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies.
Front Mol Neurosci. 2011;4:24. PubMed: 22007157PAPER Iglesias JE, Jiang J, Liu CY, Tu Z,
Classification of Alzheimer's disease using a self-smoothing operator.
Med Image Comput Comput Assist Interv. 2011;14(Pt 3):58-65. PubMed: 22003684PAPER Barone E, Mancuso C, Di Domenico F, Sultana R, Murphy MP, Head E, Butterfield DA
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease.
J Neurochem. 2012 Jan;120(1):135-146. PubMed: 22004509PAPER Hollingworth P, Sweet R, Sims R, Harold D, Russo G, Abraham R, Stretton A, Jones N, Gerrish A, Chapman J, Ivanov D, Moskvina V, Lovestone S, Priotsi P, Lupton M, Brayne C, Gill M, Lawlor B, Lynch A, Craig D, McGuinness B, Johnston J, Holmes C, Livingston G, Bass NJ, Gurling H, McQuillin A, , Holmans P, Jones L, Devlin B, Klei L, Barmada MM, Demirci FY, Dekosky ST, Lopez OL, Passmore P, Owen MJ, O'Donovan MC, Mayeux R, Kamboh MI, Williams J
Genome-wide association study of Alzheimer's disease with psychotic symptoms.
Mol Psychiatry. 2011 Oct 18; PubMed: 22005930John Kaiser
Denysias BioScienceRancho Santa Fe, United States
Geoffrey Johnson
Mayo ClinicRochester, United States
PAPER Bensman A, Milhaud G
[Persistent nephrotic syndrome in a child: blood levels of 25 hydroxyvitamin D].
Nouv Presse Med. 1979 Apr 7;8(16):1351. PubMed: 90364PAPER Kort J, Rendl KH
[Surgical treatment of cholelithiasis. Comparison of results 1953-1957 and 1968-1972].
Med Welt. 1977 Apr 29;28(17):812-6. PubMed: 875697PAPER Chadchankar H, Yavich L
Sub-regional differences and mechanisms of the short-term plasticity of dopamine overflow in striatum in mice lacking alpha-synuclein.
Brain Res. 2011 Nov 14;1423:67-76. PubMed: 22000591PAPER Cersosimo MG, Benarroch EE
Autonomic involvement in Parkinson's disease: Pathology, pathophysiology, clinical features and possible peripheral biomarkers.
J Neurol Sci. 2012 Feb 15;313(1-2):57-63. PubMed: 22001247PAPER Martins M, Rosa A, Guedes LC, Fonseca BV, Gotovac K, Violante S, Mestre T, Coelho M, Rosa MM, Martin ER, Vance JM, Outeiro TF, Wang L, Borovecki F, Ferreira JJ, Oliveira SA
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease.
PLoS One. 2011;6(10):e25443. PubMed: 22003392PAPER Rossi D, De Grandis E, Barzaghi C, Mascaretti M, Garavaglia B, Zanotto E, Morana G, Biancheri R
Early-onset neurodegeneration with brain iron accumulation due to PANK2 mutation.
Brain Dev. 2011 Oct 13; PubMed: 21999968PAPER Gorąca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B
Lipoic acid- biological activity and therapeutic potential.
Pharmacol Rep. 2011;63(4):849-58. PubMed: 22001972PAPER Jeffrey M, Scholes SF, Martin S, McGovern G, Sisó S, González L
Increased Immunohistochemical Labelling for Prion Protein Occurs in Diverse Neurological Disorders of Sheep: Relevance for Normal Cellular PrP Function.
J Comp Pathol. 2011 Oct 13; PubMed: 22000036Current Filters
No filters selected